VEGF is a secreted mitogen associated with angiogenesis and is also a poten
t vascular permeability factor. The biological role of VEGF in the ischemic
brain remains unknown. This study was undertaken to investigate whether VE
GF enhances cerebral microvascular perfusion and increases blood-brain barr
ier (BBB) leakage in the ischemic brain. Using magnetic resonance imaging (
MRI), three-dimensional laser-scanning confocal microscope, and functional
neurological tests, we measured the effects of administrating recombinant h
uman VEGF(165) (rhVEGF(165)) On angiogenesis, functional neurological outco
me, and BBB leakage in a rat model of focal cerebral embolic ischemia. Late
(48 hours) administration of rhVEGF(165) to the ischemic rats enhanced ang
iogenesis in the ischemic penumbra and significantly improved neurological
recovery. However, early postischemic (1 hour) administration of rhVEGF(165
) to ischemic rats significantly increased BBB leakage, hemorrhagic transfo
rmation, and ischemic lesions. Administration of rhVEGF(165) to ischemic ra
ts did not change BBB leakage and cerebral plasma perfusion in the contrala
teral hemisphere. Our results indicate that VEGF can markedly enhance angio
genesis in the ischemic brain and reduce neurological deficits during strok
e recovery and that inhibition of VEGF at the acute stage of stroke may red
uce the BBB permeability and the risk of hemorrhagic transformation after f
ocal cerebral ischemia.